(Q62813977)

English

Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis

clinical trial

Statements

VISIONARY-MS (English)
0 references
A Phase 2, Randomized, DB-PC, Parallel Group Study for the Treatment of Visual Pathway Deficits In Chronic Optic Neuropathy to Assess the Efficacy, Safety, Tolerability and Pharmacokinetics of CNM-Au8 For Remyelination In Multiple Sclerosis (English)
0 references
0 references
0 references
0 references
0 references
0 references
23 November 2018
0 references
30 December 2019
0 references
150
0 references
18 year
0 references
50 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit